PRESS RELEASE published on 10/14/2024 at 16:00, 1 year 3 months ago Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF published on 10/09/2024 at 20:06, 1 year 3 months ago Laxxon Medical to Present SPID® Technology at CPHI Milan 2024 Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
BRIEF published on 10/09/2024 at 20:06, 1 year 3 months ago Laxxon Medical présentera la technologie SPID® au CPHI Milan 2024 Laxxon Medical Fabrication Pharmaceutique Technologie SPID® CPHI Milan 2024 Technologie D'impression CGMP
PRESS RELEASE published on 10/09/2024 at 20:01, 1 year 3 months ago Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF published on 10/01/2024 at 15:05, 1 year 4 months ago Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF published on 10/01/2024 at 15:05, 1 year 4 months ago Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE published on 10/01/2024 at 15:00, 1 year 4 months ago Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF published on 05/22/2024 at 15:10, 1 year 8 months ago Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
BRIEF published on 05/22/2024 at 15:10, 1 year 8 months ago Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE published on 05/22/2024 at 15:05, 1 year 8 months ago Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed
Published on 02/04/2026 at 00:00, 1 hour 55 minutes ago Sintana Energy Inc. Announces VMM-37 Resolution
Published on 02/03/2026 at 23:30, 2 hours 25 minutes ago FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 2 hours 43 minutes ago Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 3 hours 25 minutes ago Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million
Published on 02/03/2026 at 22:25, 3 hours 30 minutes ago VIDAA Selects Amdocs MarketONE to Power a New Generation of OTT Subscription and Streaming Bundles on Smart TVs
Published on 02/04/2026 at 00:42, 1 hour 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3X - Initial Director's Interest Notice
Published on 02/03/2026 at 20:57, 4 hours 58 minutes ago EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year
Published on 02/03/2026 at 20:36, 5 hours 18 minutes ago Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 5 hours 50 minutes ago KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026
Published on 02/03/2026 at 18:00, 7 hours 55 minutes ago Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 8 hours 10 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 8 hours 10 minutes ago Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)